• YouTube
    • Facebook

    GRESP GRESP

    • Início
    • Sobre Nós
      • Comissão Coordenadora
      • Objetivos
      • Grupos de Trabalho
        • Doença Pulmonar Obstrutiva Crónica
        • Asma e Rinite
        • Apneia do Sono e Cuidados Respiratórios Domiciliários
        • Doenças Infeciosas
        • Doenças Oncológicas Respiratórias
        • Reabilitação Respiratória
        • Tabagismo
        • Dispositivos inalatórios
        • Formação e Investigação
        • Prevenção
        • Comunicacao e Digital
        • Avaliação Funcional Respiratória
      • Patrocínio Científico
      • Novas Inscrições
    • Eventos
    • Recursos
      • Minuto GRESP
      • Folhetos / Guias práticos
      • Vídeos
        • Dispositivos Inalatórios e Técnica Inalatória
        • Reabilitação Respiratória
      • Testes e questionários
        • ADO Index
        • BODE e BODEx
        • DOSE
        • Measurement of Health-Related Quality of Life & Asthma Control
      • Recursos por tema
        • Asma e Rinite
        • DPOC
        • Avaliação funcional respiratória
        • SAOS e CRD
        • Dispositivos inalatórios e técnica inalatória
        • Doenças respiratórias infeciosas
        • Tabagismo
        • Vacinação
      • Leituras / Discussão
    • Galeria
    • Contatos
    • Links Úteis

    A Não Perder

    • Ten years of tiotropium: clinical impact and patient perspectives
    • Atopy is a risk factor for respiratory symptoms in COPD patients: results from the EUROSCOP study
    • Exploring factors influencing asthma control and asthma-specific health-related quality of life among children
    • [ BROKEN LINK ] NICE recommends omalizumab across all age-groups from 6 years of age
    • COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study
    • GOLD COPD categories are not fit for purpose in primary care
    • [ BROKEN LINK ] Practical approach to exercise-induced bronchoconstriction in athletes
    • [ BROKEN LINK ] Practical approach to managing exercise-induced asthma in children and adults
    • Chronic obstructive pulmonary disease as a cardiovascular risk factor: results of a case-control study (CONSISTE study)
    • Pollen exposure in pregnancy and infancy and risk of asthma hospitalisation – a register based cohort study
    • Second hand smoke exposure and the risk of invasive meningococcal disease in children: systematic review and meta-analysis
    • [ BROKEN LINK ] Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care
    • Efficacy of pulmonary rehabilitation in patients with moderate chronic obstructive pulmonary disease: a randomized controlled trial
    • [ BROKEN LINK ] Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy
    • [ BROKEN LINK ] 21st-Century Hazards of Smoking and Benefits of Cessation in the United States
    • Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13 – a rapid epidemiological and virological assessment
    • Early and unexpectedly severe start of influenza epidemic in the Czech Republic during influenza season 2012-13
    • [ BROKEN LINK ] Obesity is associated with increased asthma severity and exacerbations, and increased serum immunoglobulin E in inner-city adults
    • [ BROKEN LINK ] Asthma and mental health among youth: etiology, current knowledge and future directions
    • [ BROKEN LINK ] Elite athletes with asthma: is the management goal total control?
    • Airway Obstruction and Bronchodilator Responsiveness in Adults With Acute Cough
    • How Long Does a Cough Last? Comparing Patients’ Expectations With Data From a Systematic Review of the Literature
    • Attitudes of asthmatic and nonasthmatic children to physical exercise
    • New Evidence That Cigarette Smoking Remains the Most Important Health Hazard
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26

    Gresp no Facebook

    Siga-nos no Facebook e fique a par de todas as novidades na área das doenças respiratórias.

    APMGFIPCRG

    Contatos

    Mail: gresp@apmgf.pt

    • Novas inscrições
    • Patrocínio científico

    Associação Portuguesa de Medicina Geral e Familiar

    Av. da República, 97 – 1.º
    1050-190 Lisboa – Portugal
    Telf. +351 217 615 250
    Fax: +351 217 933 145

    © 2025 GRESP. Todos os direitos reservados